Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds-News

13G Filing: Knoll Capital Management Holding Firm to Stake in Ampio Pharmaceuticals, Inc. (AMPE)

Published on March 1, 2016 at 2:56 pm by Meena Krishnamsetty in Hedge Funds, News
Page 1 of 7
Next >>

Fred Knoll‘s Knoll Capital Management has issued three Form 13G filings today, including this one on Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE), which represented the fund’s second-largest holding on December 31. The current position of 3.39 million shares, 6.5% of the company’s outstanding shares, is unchanged from the end of 2015. You can see the details of the filing below.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Knoll Capital Management 0 3,388,322 0 3,388,322 3,388,322 6.5%
Fred Knoll 0 3,388,322 0 3,388,322 3,388,322 6.5%
Gakasa Holdings 0 3,388,322 0 3,388,322 3,388,322 6.5%

Follow Fred Knoll's Knoll Capital Management

Page 1 of 7 SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
SCHEDULE 13G*
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2
(Amendment No. __)
Ampio Pharmaceuticals, Inc
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)

03209T109
(CUSIP Number)

February
16, 2016
(Date of Event Which Requires Filing of the Statement)

Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

*The remainder of this
cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover
page.

The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes)

Page 1 of 7

Follow Ampio Pharmaceuticals Inc. (NYSE:AMPE)
Page 1 of 7
Next >>

Show more...Show less